Trial intelligence / Profile preview

Optimization of Midazolam Administration Timing in Pediatric Adenotonsillectomy

NCT07622641Not yet recruiting

Sponsor
Erzurum City Hospital
Start
Aug 2026
Primary completion
Aug 2027
Countries
1
01

Overview

Randomised, open-label trial of midazolam in preoperative anxiety, Surgical stress response and postoperative pain (2 arms), sponsored by Erzurum City Hospital. Primary endpoint: Change in Serum Cortisol Levels. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

midazolam
03

Conditions

preoperative anxietySurgical stress responsepostoperative pain

Beyond the preview

Go deeper on NCT07622641.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07622641.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call